BioSpace News Archive

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019, at 9:30 a.m. PST in San Francisco.

Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended December 1, 2018.

Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shanghai) Ltd. to initiate global clinical development of E6201, a potent MEK1 inhibitor with excellent brain penetration.

Faruqi & Faruqi, LLP, reminds investors in Nobilis Health Corp. of the February 12, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Today, AB InBev, the world’s leading brewer, and Tilray, a global pioneer in cannabis production and distribution, announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the High Court of Justice of Antigua and Barbuda rejected the claim of 1Globe Capital LLC (“1Globe”) for a declaration that an alternative slate of directors had been elected at the Company’s Annual General Meeting in February 2018

Major education organizations call on federal government to focus its next steps on resources and training more mental health specialists to ensure safety of students and school staff

Cure Alzheimer’s Fund has been selected by Forbes for its annual 12 Days of Charitable Giving List. Forbes features a charity in each of the 12 days before Christmas, providing charitable inspiration to millions of readers.

Teledyne Technologies Incorporated (NYSE:TDY) (“Teledyne”) and Roper Technologies, Inc. (NYSE:ROP) (“Roper”) jointly announced today that they have entered into a definitive agreement under which Teledyne will acquire the Scientific Imaging businesses of Roper for $225 million in cash

Rite Aid Corporation (NYSE:RAD) and McKesson Corporation (NYSE:MCK) announced an agreement to key terms that will continue the companies’ pharmaceutical sourcing and distribution partnership for an additional 10 years.